Children receiving multiple antibiotic courses between birth and age 2 years may have a higher risk for some chronic ...

Metabolic syndrome is associated with increased risk for early-onset all-cause dementia, Alzheimer’s disease, and vascular ...

Akeso has shared for the first time overall survival data from a high-profile Keytruda head-to-head trial for its PD-1xVEGF ...

Febuxostat does not appear to increase the risk for major adverse cardiovascular events when compared with no urate-lowering ...

For patients with clinically isolated syndrome, vitamin D supplementation resulted in less frequent MRI activity and fewer ...

Summit Therapeutics highlights China approval of Akeso's ivonescimab for NSCLC, with enrollment ongoing for Phase 3 HARMONi-7 ...

For patients with mitral valve prolapse (MVP) and mitral regurgitation (MR), mitral annular disjunction (MAD) is associated ...

Quoc-Dien Trinh, MD, MBA, discusses a sub-analysis of the phase 3 ARANOTE trial, focusing on Black patients with metastatic ...